Shimamura, Akiko
Harvard Medical School,
United States
2025 Rank: 80004
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2200 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80004 | 85113 |
| Total Cites | 9707 | 11196 |
| H-index | 50 | 51 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 164 | 178 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 1002 | 1113 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 3088 | 3484 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7730 | 8550 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
13.30%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2024 Rank: 82340
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2290 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82340 | 87933 |
| Total Cites | 8380 | 9687 |
| H-index | 49 | 50 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 148 | 162 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 945 | 1057 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 2730 | 3116 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6715 | 7392 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
13.49%
|
|
Shimamura, Akiko
Children's Hospital Boston,
United States
2023 Rank: 86898
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2436 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86898 | 90973 |
| Total Cites | 7159 | 8234 |
| H-index | 45 | 48 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 140 | 152 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 890 | 1014 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 2421 | 2795 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5818 | 6354 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.30 |
| Self-Citation Percentage |
13.06%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2022 Rank: 90334
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2563 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90334 | 93738 |
| Total Cites | 6300 | 7243 |
| H-index | 42 | 44 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 127 | 139 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 826 | 947 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2105 | 2442 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5211 | 5689 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
13.02%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2021 Rank: 90533
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2559 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90533 | 94878 |
| Total Cites | 5948 | 6839 |
| H-index | 41 | 42 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 116 | 127 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 798 | 911 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 1997 | 2318 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4946 | 5399 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.27 |
| Self-Citation Percentage |
13.03%
|
|
Shimamura, Akiko
Dana-Farber Cancer Institute,
United States
2020 Rank: 98985
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2715 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98985 | 99486 |
| Total Cites | 5127 | 5918 |
| H-index | 37 | 40 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 105 | 116 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 726 | 834 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 1663 | 1953 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4325 | 4734 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
13.37%
|
|